Indicators of increased breast cancer risk in humans
- PMID: 1469898
- DOI: 10.1002/jcb.240501130
Indicators of increased breast cancer risk in humans
Abstract
Specific atypical histological patterns of epithelial hyperplasia (AH) indicate a medically relevant risk of breast cancer development in 5-10% of women with otherwise benign biopsies. This risk is about four times that of similar women, i.e., of the same age and at risk for the same length of time. These relative risks are not stable with time and fall 10-15 years after detection. Absolute risk for invasive breast cancer after AH is about 10% in 10-15 years after biopsy and is most certain for perimenopausal women. Proliferative disease without atypia predicts only a slight elevation of risk with a relative risk (RR) of 1.5 to 2 times that of the general population. There is such a strong interaction between family history and AH that it is relevant to consider women with atypical hyperplasia who have a positive family history (FH) of breast cancer separately from those who do not. The absolute risk of breast cancer development in women with AH without a FH was 8% in 10 years (RR about 4), whereas those with a positive family history experienced a risk of about 20% at 15 years (RR of about 10). This interaction of AH and FH has also been observed in other recent studies. Low replacement doses of conjugated estrogen after menopause do not further elevate risk beyond that identified by histology.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Evaluation and management of high risk and premalignant lesions of the breast.World J Surg. 1994 Jan-Feb;18(1):32-8. doi: 10.1007/BF00348189. World J Surg. 1994. PMID: 8197774 Review.
-
Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast cancer.Cancer Epidemiol Biomarkers Prev. 1996 Jan;5(1):29-32. Cancer Epidemiol Biomarkers Prev. 1996. PMID: 8770463
-
Breast cancer risk associated with proliferative breast disease and atypical hyperplasia.Cancer. 1993 Feb 15;71(4):1258-65. doi: 10.1002/1097-0142(19930215)71:4<1258::aid-cncr2820710415>3.0.co;2-i. Cancer. 1993. PMID: 8435803 Review.
-
The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):105-15. doi: 10.1016/s0360-3016(98)00181-3. Int J Radiat Oncol Biol Phys. 1998. PMID: 9747827
-
Invasive breast cancer risk in women with sclerosing adenosis.Cancer. 1989 Nov 15;64(10):1977-83. doi: 10.1002/1097-0142(19891115)64:10<1977::aid-cncr2820641002>3.0.co;2-n. Cancer. 1989. PMID: 2804888
Cited by
-
The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification.Breast Cancer Res. 2003;5(5):254-7. doi: 10.1186/bcr623. Epub 2003 Jul 29. Breast Cancer Res. 2003. PMID: 12927035 Free PMC article. Review.
-
Mammary epithelial hyperplasias: alterations related solely to proliferation?Breast Cancer Res Treat. 1996;41(2):95-101. doi: 10.1007/BF01807154. Breast Cancer Res Treat. 1996. PMID: 8944327
-
Multiplex genotype analysis of invasive carcinoma and accompanying proliferative lesions microdissected from breast tissue.J Mol Diagn. 2000 Feb;2(1):29-36. doi: 10.1016/S1525-1578(10)60612-5. J Mol Diagn. 2000. PMID: 11272899 Free PMC article.
-
Cellular localisation by in situ hybridisation of cathepsin D, stromelysin 3, and urokinase plasminogen activator RNAs in breast cancer.Breast Cancer Res Treat. 1996;38(2):217-26. doi: 10.1007/BF01806676. Breast Cancer Res Treat. 1996. PMID: 8861840
Publication types
MeSH terms
LinkOut - more resources
Medical
Miscellaneous